Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Mersana Therapeutics | MRSN | Jan 10, 2025 | 0.72 | -44.62 |
Merus N.V | MRUS | Jan 10, 2025 | 43.85 | +3.84 |
Mesa Air Group | MESA | Jan 10, 2025 | 1.36 | +0.74 |
Mesa Laboratories | MLAB | Jan 10, 2025 | 134.39 | -5.38 |
Mesa Royalty Trust | MTR | Jan 10, 2025 | 6.34 | +2.57 |
Mesabi Royalty Trust | MSB | Jan 10, 2025 | 26.65 | -0.30 |
Mesoblast ADR | MESO | Jan 10, 2025 | 17.18 | 0.00 |
Meta Platforms A | META | Jan 10, 2025 | 615.86 | +0.84 |
Metagenomi | MGX | Jan 10, 2025 | 3.13 | +1.29 |
Metal Sky Star Acquisition | MSSA | Jan 10, 2025 | 12.10 | -3.20 |
Metalla Royalty & Streaming | MTA | Jan 10, 2025 | 2.62 | 0.00 |
Metallus | MTUS | Jan 10, 2025 | 13.52 | +0.90 |
MetaVia | MTVA | Jan 10, 2025 | 2.06 | 0.00 |
Methalpa Technology Holding | MATH | Jan 10, 2025 | 1.66 | 0.00 |
Methanex | MEOH | Jan 10, 2025 | 47.71 | -1.53 |
Methode Electronics | MEI | Jan 10, 2025 | 10.97 | -2.05 |
MetLife | MET | Jan 10, 2025 | 80.25 | -3.10 |
Metlife Pref A | MET-A | Jan 10, 2025 | 24.87 | -0.36 |
Metlife Pref E | MET-E | Jan 10, 2025 | 22.97 | -2.67 |
Metlife Pref F | MET-F | Jan 10, 2025 | 20.29 | -1.65 |
MetroCity Bankshares | MCBS | Jan 10, 2025 | 29.74 | -5.04 |
Metropolitan Bank | MCB | Jan 10, 2025 | 56.34 | -0.95 |
Mettler-Toledo International | MTD | Jan 10, 2025 | 1 210.99 | -2.85 |
Mexco Energy | MXC | Jan 10, 2025 | 12.78 | -3.01 |
Mexico Equity And Income Fund | MXE | Jan 10, 2025 | 8.11 | -1.93 |
Mexico Fund | MXF | Jan 10, 2025 | 13.35 | -1.07 |
Mexico Investable Mkt Idx MSCI Ishares | EWW | Jan 10, 2025 | 47.14 | -1.65 |
mF International | MFI | Jan 10, 2025 | 0.75 | -9.00 |
MFA Financial | MFA | Jan 10, 2025 | 9.55 | -4.02 |
MFA Financial B Pref | MFA-B | Jan 10, 2025 | 20.75 | -2.07 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.